1
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: state
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Provisor AJ, Ettinger LJ, Nachman JB,
Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES,
Kisker CT and Miser JS: Treatment of nonmetastatic osteosarcoma of
the extremity with preoperative and postoperative chemotherapy: a
report from the Children's Cancer Group. J Clin Oncol. 15:76–84.
1997.
|
3
|
Ferguson WS and Goorin AM: Current
treatment of osteosarcoma. Cancer Invest. 19:292–315. 2001.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Eckert RL, Broome AM, Ruse M, Robinson N,
Ryan D and Lee K: S100 proteins in the epidermis. J Invest
Dermatol. 123:23–33. 2004. View Article : Google Scholar : PubMed/NCBI
|
5
|
Donato R: Intracellular and extracellular
roles of S100 proteins. Microsc Res Tech. 60:540–551. 2003.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Salama I, Malone PS, Mihaimeed F and Jones
JL: A review of the S100 proteins in cancer. Eur J Surg Oncol.
34:357–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
7
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: a small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Madsen P, Rasmussen HH, Leffers H, Honoré
B, Dejgaard K, Olsen E, Kiil J, Walbum E, Andersen AH, Basse B, et
al: Molecular cloning, occurrence, and expression of a novel
partially secreted protein ‘psoriasin’ that is highly up-regulated
in psoriatic skin. J Invest Dermatol. 97:701–712. 1991.PubMed/NCBI
|
9
|
Wolf R, Howard OM, Dong HF, Voscopoulos C,
Boeshans K, Winston J, Divi R, Gunsior M, Goldsmith P, Ahvazi B, et
al: Chemotactic activity of S100A7 (Psoriasin) is mediated by the
receptor for advanced glycation end products and potentiates
inflammation with highly homologous but functionally distinct
S100A15. J Immunol. 181:1499–1506. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Engelkamp D, Schäfer BW, Mattei MG, Erne P
and Heizmann CW: Six S100 genes are clustered on human chromosome
1q21: identification of two genes coding for the two previously
unreported calcium-binding proteins S100D and S100E. Proc Natl Acad
Sci USA. 90:6547–6551. 1993. View Article : Google Scholar
|
11
|
Rodan SB, Imai Y, Thiede MA, Wesolowski G,
Thompson D, Bar-Shavit Z, Shull S, Mann K and Rodan GA:
Characterization of a human osteosarcoma cell line (Saos-2) with
osteoblastic properties. Cancer Res. 47:4961–4966. 1987.PubMed/NCBI
|
12
|
Soule HD, Vazguez J, Long A, Albert S and
Brennan M: A human cell line from a pleural effusion derived from a
breast carcinoma. J Natl Cancer Inst. 51:1409–1416. 1973.PubMed/NCBI
|
13
|
Bai L, Mihara K, Kondo Y, Honma M and
Namba M: Immortalization of normal human fibroblasts by treatment
with 4-nitroquinoline 1-oxide. Int J Cancer. 53:451–456. 1993.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Kawai A, Ozaki T, Ikeda S, Oda T, Miyazaki
M, Sato J, Taketa K and Inoue H: Two distinct cell lines derived
from a human osteosarcoma. J Cancer Res Clin Oncol. 115:531–536.
1989. View Article : Google Scholar : PubMed/NCBI
|
15
|
Yamamoto K, Sakaguchi M, Medina RJ, Niida
A, Sakaguchi Y, Miyazaki M, Kataoka K and Huh NH: Transcriptional
regulation of a brown adipocyte-specific gene, UCP1, by KLF11 and
KLF15. Biochem Biophys Res Commun. 400:175–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kataoka K and Huh NH: A novel
beta1,3-N-acetylglucosaminyltransferase involved in invasion of
cancer cells as assayed in vitro. Biochem Biophys Res Commun.
294:843–848. 2002. View Article : Google Scholar : PubMed/NCBI
|
17
|
Foell D, Wittkowski H, Vogl T and Roth J:
S100 proteins expressed in phagocytes: a novel group of
damage-associated molecular pattern molecules. J Leukoc Biol.
81:28–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Neeper M, Schmidt AM, Brett J, Yan SD,
Wang F, Pan YC, Elliston K, Stern D and Shaw A: Cloning and
expression of a cell surface receptor for advanced glycosylation
end products of proteins. J Biol Chem. 267:14998–15004.
1992.PubMed/NCBI
|
19
|
Yan SF, Ramasamy R and Schmidt AM:
Mechanisms of disease: advanced glycation end-products and their
receptor in inflammation and diabetes complications. Nat Clin Pract
Endocrinol Metab. 4:285–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
20
|
Rojas A, Figueroa H and Morales E: Fueling
inflammation at tumor microenvironment: the role of
multiligand/RAGE axis. Carcinogenesis. 31:334–341. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sparvero LJ, Asafu-Adjei D, Kang R, Tang
D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ and Lotze
MT: RAGE (Receptor for Advanced Glycation Endproducts), RAGE
ligands, and their role in cancer and inflammation. J Transl Med.
7:172009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Riehl A, Németh J, Angel P and Hess J: The
receptor RAGE: Bridging inflammation and cancer. Cell Commun
Signal. 7:122009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Albini A and Benelli R: The chemoinvasion
assay: a method to assess tumor and endothelial cell invasion and
its modulation. Nat Protoc. 2:504–511. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
25
|
Xin ZF, Kim YK and Jung ST: Risedronate
inhibits human osteosarcoma cell invasion. J Exp Clin Cancer Res.
28:1052009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Emberley ED, Murphy LC and Watson PH:
S100A7 and the progression of breast cancer. Breast Cancer Res.
6:153–159. 2004. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Krop I, März A, Carlsson H, Li X,
Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy
S, et al: A putative role for psoriasin in breast tumor
progression. Cancer Res. 65:11326–11334. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Hiratsuka S, Watanabe A, Sakurai Y,
Akashi-Takamura S, Ishibashi S, Miyake K, Shibuya M, Akira S,
Aburatani H and Maru Y: The S100A8-serum amyloid A3-TLR4 paracrine
cascade establishes a pre-metastatic phase. Nat Cell Biol.
10:1349–1355. 2008. View
Article : Google Scholar : PubMed/NCBI
|
29
|
Andresen E, Lange C, Strodthoff D,
Goldmann T, Fischer N, Sahly H, Branscheid D and Heine H:
S100A7/psoriasin expression in the human lung: unchanged in
patients with COPD, but upregulated upon positive S. aureus
detection. BMC Pulm Med. 11:102011. View Article : Google Scholar : PubMed/NCBI
|